P00533 (EGFR_HUMAN) Homo sapiens (Human)

Epidermal growth factor receptor UniProtKBInterproStringInteractive Modelling

1210 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; )

Sequence Features

 837Proton acceptor.
 1016Important for interaction with PIK3C2B.
 98R -> Q (in dbSNP:rs17289589). VAR_019293 dbSNP
 266P -> R (in dbSNP:rs17336639). VAR_019294 dbSNP
 428G -> D (in NISBD2; loss of function; the mutant does not localize to the cell membrane; has diffuse cytoplasmic localization; dbSNP:rs606231253). VAR_072435 dbSNP
 521R -> K (in dbSNP:rs2227983). VAR_019295 dbSNP
 674V -> I (in dbSNP:rs17337079). VAR_019296 dbSNP
 709E -> A (found in a lung cancer sample; more sensitive to gefitinib than wild- type; dbSNP:rs397517085). VAR_026084 dbSNP
 709E -> G (found in a lung cancer sample; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs397517085). VAR_069498 dbSNP
 709E -> K (found in a lung cancer sample; dbSNP:rs727504256). VAR_026085 dbSNP
 719G -> A (found in a lung cancer sample; dbSNP:rs121913428). VAR_026086 dbSNP
 719G -> C (found in a lung cancer sample; dbSNP:rs28929495). VAR_026087 dbSNP
 719G -> D (found in a lung cancer sample; dbSNP:rs121913428). VAR_026088 dbSNP
 719G -> S (found in a lung cancer sample; somatic mutation; strongly increased kinase activity; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs28929495). VAR_019297 dbSNP
 724G -> S (found in a lung cancer sample). VAR_026089
 734E -> K (found in a lung cancer sample; dbSNP:rs121913420). VAR_026090 dbSNP
 746Missing (found in a lung cancer sample). VAR_026091
 747L -> F (found in a lung cancer sample). VAR_026093
 748R -> P (found in a lung cancer sample). VAR_026095
 768S -> I (found in a lung cancer sample; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs121913465). VAR_069502 dbSNP
 769V -> M (found in a lung cancer sample; dbSNP:rs147149347). VAR_069503 dbSNP
 787Q -> R (found in a lung cancer sample). VAR_026097
 790T -> M (found in a lung cancer sample; increased kinase activity; dbSNP:rs121434569). VAR_026098 dbSNP
 833L -> V (found in a lung cancer sample; more sensitive to gefitinib than wild- type; dbSNP:rs397517126). VAR_026099 dbSNP
 834V -> L (found in a lung cancer sample; dbSNP:rs397517127). VAR_026100 dbSNP
 835H -> L (found in a lung cancer sample; more sensitive to gefitinib than wild- type; dbSNP:rs397517128). VAR_069504 dbSNP
 838L -> V (found in a lung cancer sample; more sensitive to gefitinib than wild- type; dbSNP:rs864621996). VAR_069505 dbSNP
 858L -> M (found in a lung cancer sample; dbSNP:rs121913443). VAR_026101 dbSNP
 858L -> R (found in a lung cancer sample; somatic mutation; constitutively activated enzyme with strongly increased kinase activity; more sensitive to gefitinib than wild-type; dbSNP:rs121434568). VAR_019298 dbSNP
 861L -> Q (found in a lung cancer sample; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs121913444). VAR_026102 dbSNP
 873G -> E (found in a lung cancer sample). VAR_026103
 962R -> G (in dbSNP:rs17337451). VAR_019299 dbSNP
 988H -> P (in dbSNP:rs17290699). VAR_019300 dbSNP
 1034L -> R (in dbSNP:rs34352568). VAR_042095 dbSNP
 1210A -> V (in dbSNP:rs35918369). VAR_042096 dbSNP
 646-668Helical.
 718-726ATP.
 790-791ATP.
 31-58
 157-187
 190-199
 194-207
 215-223
 219-231
 232-240
 236-248
 251-260
 264-291
 295-307
 311-326
 329-333
 337-362
 470-499
 506-515
 510-523
 526-535
 539-555
 558-571
 562-579
 582-591
 595-617
 620-628
 624-636
 30-297Missing (variant EGFR vIII; found in a lung cancer sample; somatic mutation; induces lung cancer when exogenously expressed). VAR_066493
 746-752ELREATS -> D (found in a lung cancer sample). VAR_069499
 746-751ELREAT -> A (found in a lung cancer sample). VAR_069500
 746-750Missing (found in a lung cancer sample). VAR_026092
 747-751Missing (found in a lung cancer sample). VAR_069501
 747-749Missing (found in a lung cancer sample). VAR_026094
 752-759Missing (found in a lung cancer sample). VAR_026096
 57-167Receptor L-domain
IPR000494PF01030
 185-338Furin-like cysteine-rich domain
IPR006211PF00757
 361-480Receptor L-domain
IPR000494PF01030
 505-636Growth factor receptor domain 4
IPR032778PF14843
 714-965Serine-threonine/tyrosine-protein kinase , catalytic domain
IPR001245PF07714

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownload
'Crystal structure of the extracellular domain of the epidermal growth factor receptor in complex... Heteromer
NAG;3qwq1-642
'Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Dom... Heteromer
P00533; P01133;
NAG;1ivo25-646
The complex structure of extracellular domain of EGFR and GC1118A Heteromer
NAG;4uv725-645
Structure of the extracellular domain of the epidermal growth factor receptor in complex with the... Heteromer
NAG;NDG;1yy925-642
'Structure of the extracellular domain of human epidermal growth factor (EGF) receptor in an inac... Heteromer
P01133;
NAG;1nql25-642
Nanobody/VHH domain 9G8 in complex with the extracellular region of EGFR Heteromer
NAG;4krp25-642
Nanobody/VHH domain EgA1 in complex with the extracellular region of EGFR Heteromer
NAG;4kro25-642
'Crystal structure of the extracellular region of the epidermal growth factor receptor in complex... Heteromer
Q6GMX6;
NAG;3b2v25-642
'The Extracellular and Transmembrane Domain Interfaces in Epidermal Growth Factor Receptor Signal... Heteromer
P00533; P01133;
2PE; 12×NAG;3njp25-638
The complex structure of extracellular domain of EGFR with Repebody (rAC1). Heteromer
E0ACT6; Q4G1L3;
NAG;4uip26-637
'Crystal Structure of Human Epidermal Growth Factor Receptor (residues 1-501) in complex with TGF... Heteromer
P00533; P01135;
CL;NAG;PT; 11×CD;1mox25-525
'Crystal structure of an EGFR/HER3 kinase domain heterodimer containing the cancer-associated HER... Heteromer
P21860;
MG;ANP;ADP;4riy682-1022
Crystal structure of an EGFR/HER3 kinase domain heterodimer Heteromer
P21860;
MG;ANP;ADP;4riw682-1022
'Crystal structure of an EGFR/HER3 kinase domain heterodimer containing the cancer-associated HER... Heteromer
P21860;
MG;ANP;ADP;4rix682-1022
EGFR L858R MUTANT IN COMPLEX WITH A SHC PEPTIDE SUBSTRATE Heteromer
P29353;
5czi694-1022
crystal structure of EGFR kinase domain in complex with Mitogen-inducible gene 6 protein Heteromer
Q9UJM3;
4zjv695-1022
Crystal structure of L858R + T790M EGFR kinase domain in complex with MIG6 peptide Heteromer
Q9UJM3;
4i21695-1022
Crystal structure of the complex between the EGFR kinase domain and a Mig6 peptide Heteromer
Q9UJM3;
2rf9696-1022
Crystal structures of EGFR in complex with Mig6 Heteromer
Q9UJM3;
4r3p696-1018
Crystal structures of EGFR in complex with Mig6 Heteromer
Q9UJM3;
4r3r696-1018
Crystal structure of the complex between the EGFR kinase domain and a Mig6 peptide Heteromer
Q9UJM3;
2rfe702-1022
Crystal structure of the complex between the EGFR kinase domain and a Mig6 peptide Heteromer
Q9UJM3;
SO4;2rfd702-1022
anti-EGFR/HER3 Fab DL11 in complex with domain III of EGFR extracellular region Heteromer
GOL;3p0y334-538
Crystal structure of isolated domain III of the extracellular region of the epidermal growth fact... Heteromer
Q6GMX6;
NAG;SO4;3b2u335-538
Nanobody/VHH domain 7D12 in complex with domain III of the extracellular region of EGFR, pH 3.5 Heteromer
NAG;4krm335-538
Nanobody/VHH domain 7D12 in complex with domain III of the extracellular region of EGFR, pH 6.0 Heteromer
IOD;NAG;MES;4krl335-538
'Crystal structure the Fab fragment of matuzumab (Fab72000) in complex with domain III of the ext... Heteromer
BMA;NAG;3c09336-538
'Crystal Structure of panitumumab in complex with epidermal growth factor receptor domain 3 mutan... Heteromer
GOL;1PE;SO4;EDO;5sx5335-525
Crystal Structure of panitumumab in complex with epidermal growth factor receptor domain 3. Heteromer
GOL;SO4;1PE;5sx4335-525
'Heterodimeric association of Transmembrane domains of ErbB1 and ErbB2 receptors Enabling Kinase ... Heteromer
P04626;
2ks1634-677
Antibodies Specifically Targeting a Locally Misfolded Region of Tumor Associated EGFR Heteromer
3g5y311-326
Antibodies Specifically Targeting a Locally Misfolded Region of Tumor Associated EGFR Heteromer
GOL;FMT;ACT;3g5v311-326
'Crystal structure of the tyrosine kinase binding domain of Cbl-c in complex with phospho-EGFR pe... Heteromer
Q9ULV8;
CA;3vrp1062-1074
'Crystal structure of the tyrosine kinase binding domain of Cbl-c (PL mutant) in complex with pho... Heteromer
Q9ULV8;
CA;3vrr1062-1074
Crystal structure of c-Cbl-TKB domain complexed with its binding motif in EGF receptor' Heteromer
P22681;
3buo1063-1075
Crystal structure of c-Cbl TKB domain in complex with double phosphorylated EGFR peptide Heteromer
P22681;
3ob21063-1074
Crystal structure of Cbl-b TKB domain in complex with EGFR pY1069 peptide Heteromer
Q13191;
NA;EDO;SO4;CL;3pfv1066-1076
Crystal structure of Cbl-c (Cbl-3) TKB domain in complex with EGFR pY1069 peptide Heteromer
P00533; Q9ULV8;
NA;NI;3op01066-1076
Crystal structure of the EGF receptor juxtamembrane and kinase domainshomo-2-mer 3gop669-1022
Crystal Structure of EGFR 696-1022 T790M Mutant Covalently Binding to WZ4002homo-2-mer 0UN;3ika694-1022
Crystal structure of EGFR 696-1022 T790M in complex with QL-X138homo-2-mer 3LH;CL;4wd5694-1022
EGFR L858R/T790M in complex with PD168393homo-2-mer YUN;4ll0694-1022
Structure of the monomeric (V948R)gefitinib/erlotinib resistant double mutant (L858R+T790M) EGFR ...homo-2-mer IRE;SO4;4i22695-1022
Structure of T790M EGFR kinase domain co-crystallized with dacomitinibhomo-2-mer 1C9;4i24695-1022
Crystal structure of EGFR 696-1022 T790M/V948R, crystal form IIhomo-2-mer MG;ANP;4zse695-1022
EGFR kinase domain in complex with mutant selective allosteric inhibitorhomo-2-mer MG;ANP;57N;5d41695-1022
Crystal structure of the mutated EGFR kinase domain (G719S/T790M) in complex with AMPPNP.homo-2-mer ANP;3vjn695-1022
Crystal structure of mutated EGFR kinase domain (G719S)homo-2-mer 2eb2695-1022
Crystal structure of the mutated EGFR kinase domain (G719S/T790M) in complex with gefitinibhomo-2-mer IRE;MES;3ug2695-1022
Crystal structure of the wild-type EGFR kinase domain in complex with AMPPNP.homo-2-mer ANP;3vjo695-1022
Crystal structure of the mutated EGFR kinase domain (G719S/T790M) in the apo formhomo-2-mer MES;3ug1695-1022
Crystal structure of mutated EGFR kinase domain (L858R) in complex with AMPPNPhomo-2-mer ANP;2eb3695-1022
'Crystal Structure of the active EGFR kinase domain in complex with an ATP analog-peptide conjugate'homo-2-mer 112;CL;2gs6696-1022
Crystal Structure of the inactive EGFR kinase domain in complex with AMP-PNPhomo-2-mer MG; 11×IOD;ANP;2gs7696-1022
Crystal Structure of the active EGFR kinase domainhomo-2-mer 2gs2696-1022
Crystal structure of EGFR kinase in complex with BIBW2992homo-2-mer 0WN;0WM;4g5j696-1022
Crystal structure of the inactive EGFR kinase domain in complex with AMP-PNPhomo-2-mer MG;ANP;3gt8696-1022
Crystal structure of EGFR kinase T790M in complex with BIBW2992homo-2-mer 0WN;4g5p696-1022
Crystal structure of EGFR kinase domain in complex with compound 3ghomo-2-mer KJR;4jr3696-1021
Crystal structure of EGFR kinase domain in complex with compound 2ahomo-2-mer KJQ;4jq7696-1021
Crystal structure of EGFR kinase domain in complex with compound 4chomo-2-mer KJV;4jrv696-1021
Crystal structure of EGFR kinase domain in complex with compound 4bhomo-2-mer KJ8;4jq8696-1021
'EGFR-K IN COMPLEX WITH N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxy-phenyl] ...homo-2-mer NA;1WY;4li5696-1020
'EGFR transmembrane - juxtamembrane (TM-JM) segment in bicelles: MD guided NMR refined structure.'homo-2-mer 2m20642-697
N-terminal motif dimerization of EGFR transmembrane domain in bicellar environmenthomo-2-mer 5lv6634-677
'Homodimeric transmembrane domain of the human receptor tyrosine kinase ErbB1 (EGFR, HER1) in mic...homo-2-mer 2m0b634-677
Crystal structure of the EGFR kinase domain mutant I682Qmonomer MG;ANP;5cnn696-1042
EGFR L858R in complex with PD168393monomer DJK;CL;4lqm694-1022
EGFR L858R MUTANT IN COMPLEX WITH AN OPTIMAL PEPTIDE SUBSTRATEmonomer 5czh694-1022
EGFR D770_N771insNPG in complex with PD168393monomer YUN;4lrm694-1022
Crystal structure of the EGFR kinase domain (L858R, T790M, V948R) in complex with a covalent inhi...monomer GOL;EDO;8AM;SO4;5ug9695-1022
EGFR (L858R, T790M, V948R) in complex with N-[3-({2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[...monomer GOL;634;SO4;5hg8695-1022
Crystal structure of the EGFR kinase domain (L858R, T790M, V948R) in complex with a covalent inhi...monomer GOL;8BP;SO4;5ug8695-1022
EGFR (L858R, T790M, V948R) in complex with N-{3-[(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-7H-...monomer GOL;633;SO4;5hg5695-1022
Crystal structure of the EGFR kinase domain (L858R, T790M, V948R) in complex with a covalent inhi...monomer GOL;SO4;8BS;EDO;5ugc695-1022
Crystal structure of EGFR kinase domain in complex with a sulfonyl fluoride probe XO44monomer GOL;O44;SO4;5u8l695-1022
Crystal structure of the EGFR kinase domain (L858R, T790M, V948R) in complex with 4-(4-{[2-{[(3S)...monomer 8BM;GOL;SO4;5uga695-1022
EGFR (L858R, T790M, V948R) in complex with 1-{(3R,4R)-3-[5-Chloro-2-(1-methyl-1H-pyrazol-4-ylamin...monomer 630;SO4;5hg7695-1022
EGFR kinase domain mutant "TMLR" with compound 41amonomer 4ZQ;SO4;5cas695-1022
EGFR (L858R, T790M, V948R) in complex with 1-[(3R,4R)-3-[({2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H...monomer 63A;SO4;GOL;5hg9695-1022
EGFR kinase domain mutant "TMLR" with compound 41bmonomer 4ZR;SO4;5cau695-1022
EGFR kinase domain mutant "TMLR" with compound 30monomer 4ZH;SO4;5cap695-1022
EGFR kinase domain complexed with a quinazoline inhibitor- GW572016monomer PO4;FMM;1xkk695-1022
EGFR kinase domain mutant "TMLR" with compound 23monomer 4YX;SO4;5c8n695-1022
EGFR kinase (T790M/L858R) with inhibitor compound 8monomer 3QS;SO4;4rj8695-1022
EGFR kinase domain mutant "TMLR" with compound 33monomer 4ZJ;SO4;5caq695-1022
Crystal structure of the EGFR kinase domain in complex with 4-(4-{[2-{[(3S)-1-acetylpyrrolidin-3-...monomer 8BM;5ugb695-1022
EGFR kinase (T790M/L858R) with inhibitor compound 1monomer 3R1;SO4;4rj7695-1022
EGFR kinase domain mutant "TMLR" with compound 29monomer 4ZG;5cao695-1022
EGFR kinase (T790M/L858R) with inhibitor compound 27: ~{N}-(1~{H}-indazol-3-yl)-7,7-dimethyl-2-(2...monomer 5N4;5edr695-1022
EGFR kinase domain mutant "TMLR" with a imidazopyridinyl-aminopyrimidine inhibitormonomer SO4;63N;5hic695-1022
'Epidermal Growth Factor Receptor tyrosine kinase domain with 4-anilinoquinazoline inhibitor erlo...monomer AQ4;1m17695-1022
Tyrosine Kinase Domain from Epidermal Growth Factor Receptormonomer 1m14695-1022
EGFR kinase domain mutant "TMLR" with pyridone compound 2: 4-[2-(4-chlorophenyl)ethylamino]-~{N}-...monomer 5Q2;5em5695-1022
EGFR kinase (T790M/L858R) with inhibitor compound 4monomer 3R0;SO4;4rj6695-1022
EGFR kinase domain mutant "TMLR" with compound 24monomer 4Z8;5cal695-1022
EGFR kinase domain with compound 41amonomer 4ZQ;5cav695-1022
EGFR kinase (T790M/L858R) with inhibitor compound 6monomer 3QW;4rj4695-1022
EGFR kinase domain mutant "TMLR" with pyridone compound 19: 4-[(2-azanylpyrimidin-4-yl)amino]-~{N...monomer 5Q3;SO4;5em6695-1022
EGFR kinase domain mutant "TMLR" with compound 27monomer 4ZB;SO4;5can695-1022
EGFR kinase (T790M/L858R) with inhibitor compound 15: ~{N}-(7-chloranyl-1~{H}-indazol-3-yl)-7,7-d...monomer 5N3;5edq695-1022
EGFR kinase domain with pyridone compound 13: 4-[(2-methoxyphenyl)amino]-~{N}-[4-(4-methylpiperaz...monomer 5Q4;5em8695-1022
Crystal structure of the wild-type EGFR kinase domain in complex with dacomitinib (soaked)monomer 1C9;4i23695-1022
EGFR kinase domain mutant "TMLR" with pyridone compound 13: 4-[(2-methoxyphenyl)amino]-~{N}-[4-(4...monomer SO4;5Q4;5em7695-1022
EGFR kinase domain mutant "TMLR" with a pyrazolopyrimidine inhibitormonomer 63M;5hib695-1022
EGFR kinase domain mutant "TMLR" with compound 17monomer 4YW;5c8m695-1022
EGFR kinase (T790M/L858R) apomonomer 5edp695-1022
EGFR kinase domain mutant "TMLR" with compound 1monomer 4YV;5c8k695-1022
'Crystal structure of the monomeric (V948R) form of the gefitinib/erlotinib resistant EGFR kinase...monomer 4i1z695-1022
CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPLEX WITH AEE788monomer AEE;2jiu695-1022
EGFR kinase (T790M/L858R) with inhibitor compound 5monomer 3QY;4rj5695-1022
Native-SAD phasing for human EGFR kinase domain.monomer 4tks695-1022
Crystal structure of monomeric (V948R) primary oncogenic mutant L858R EGFR kinase domainmonomer 4i20695-1022
Crystal structure of EGFR kinase domain T790M mutation in compex with HKI-272monomer HKI;2jiv695-1022
EGFR Kinase domain complexed with tak-285monomer 03P;SO4;3poz696-1022
Crystal structure of the EGFR kinase domain mutant V924Rmonomer MG;ANP;5cno696-1022
EGFR kinase domain complexed with compound 19bmonomer SO4;W19;3w33696-1022
EGFR kinase domain complexed with compound 20amonomer W32;SO4;3w32696-1022
1.85 angstrom structure of EGFR kinase domain with gefitinibmonomer NA;IRE;MES;4wkq696-1022
1.9 angstrom structure of EGFR kinase domainmonomer NA;MES;4wrg696-1022
EGFR kinase domain with compound4monomer W2R;SO4;3w2s696-1022
EGFR kinase domain mutant "TMLR" with 3-carboxamide azaindole compound 13monomer 60D;SO4;5hcy696-1022
CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AMP-PNPmonomer MG;ANP;2itn696-1022
CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AMP-PNPmonomer ANP;2itv696-1022
EGFR kinase domain mutant "TMLR" with azabenzimidazole compound 7monomer SO4;60B;5hcx696-1022
EGFR kinase domain mutant "TMLR" with 3-azetidinyl azaindazole compound 21monomer 60E;SO4;5hcz696-1022
EGFR kinase domain in complex with a covalent aminobenzimidazole inhibitor.monomer 5X4;5fed696-1022
Crystal structure of EGFR kinase domain G719S mutation in complex with AFN941monomer ITQ;2itq696-1022
EGFR kinase domain T790M mutant in complex with a covalent aminobenzimidazole inhibitor.monomer 5X4;5fee696-1022
CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AEE788monomer AEE;2itt696-1022
CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AEE788monomer AEE;2itp696-1022
Crystal structure of the inactive EGFR tyrosine kinase domain with erlotinibmonomer AQ4;4hjo696-1022
Crystal structure of EGFR 696-1022 T790M in complex with XTF-262monomer F62;5gmp696-1022
AZD9291 complex with wild type EGFRmonomer YY3;4zau696-1022
CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH IRESSAmonomer IRE;CL;2itz696-1022
Crystal structure of EGFR kinase domain L858R mutation in complex with AFN941monomer ITQ;2itu696-1022
Crystal structure of EGFR kinase domain in complex with AFN941monomer ITQ;2itw696-1022
CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNPmonomer ANP;2itx696-1022
CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR 34-JABmonomer DJK;2j5f696-1022
Crystal structure of EGFR 696-1022 L858R in complex with FIIN-3monomer FI3;4r5s696-1022
CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AEE788monomer AEE;2j6m696-1022
CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR 13-JABmonomer CL;2j5e696-1022
CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATIONmonomer 2jit696-1022
Crystal structure of EGFR kinase domain G719S mutation in complex with Iressamonomer IRE;2ito696-1022
'Crystal structure of EGFR tyrosine kinase domain with novel inhibitor of active state of HER2'monomer 6JS;SO4;5jeb696-1022
EGFR KINASE DOMAIN IN COMPLEX WITH A COVALENT AMINOBENZIMIDAZOLEmonomer 5XH;5feq696-1022
Crystal structure of EGFR kinase domain in complex with Iressamonomer IRE;2ity696-1022
EGFR Kinase domain T790M/L858R mutant with compound 4monomer W2R;EDO;3w2r698-1022
EGFR Kinase domain T790M/L858R mutant with compound 2monomer W2P;3w2p698-1022
EGFR kinase domain T790M/L858R mutant with HKI-272monomer HKI;MES;3w2q698-1022
EGFR Kinase domain T790M/L858R Mutant with TAK-285monomer 03P;3w2o698-1022
EGFR-T790M in complex with pyrazolopyrimidine inhibitor 1amonomer 6HJ;5j9z696-1020
EGFR-T790M in complex with pyrazolopyrimidine inhibitor 1bmonomer 6HL;5j9y697-1019
Structure of EGFR in complex with hydrazone, a potent dual inhibitormonomer PO4;HYZ;2rgp702-1016
X-ray structure of EGFR in complex with oxime inhibitormonomer PO4;POX;3bel702-1016
Crystal structure of EGFR 696-988 T790M in complex with LXX-6-34monomer CL; 19×EDO;80U; 11×NO3;5gnk696-988
EGFR kinase domain complexed with an imidazo[2,1-b]thiazole inhibitormonomer ITI;3lzb696-983
'A Structural Model for the Membrane-Bound Form of the Juxtamembrane Domain of the Epidermal Grow...monomer 1z9i669-721
Spatial structure of EGFR transmembrane and juxtamembrane domains in DPC micellesmonomer 2n5s642-690

Homology models built on isoform sequence

Isoform #Oligo-stateLigandsQMEANTemplateRangeSeq id (%)ReportDownload
4monomer0.384uv7.1.A26-627
100.00
3monomer-0.313qwq.1.A26-631
99.84
3monomer-0.631yy9.1.A26-648
98.21
2monomerNAG;-1.231mox.1.A26-404
99.74
4monomer-4.191ivo.1.A26-536
100.00
3monomer-4.191ivo.1.A26-536
98.53